Classification of acute myeloid leukemia

The World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues was revised in 2017 on the basis of recent high-throughput sequencing and gene expression data on hematologic malignancies. This review explores the current WHO classification of acute myeloid leukemia...

Descripción completa

Detalles Bibliográficos
Autor principal: Hwang, Sang Mee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386892/
https://www.ncbi.nlm.nih.gov/pubmed/32719169
http://dx.doi.org/10.5045/br.2020.S001
_version_ 1783564029556424704
author Hwang, Sang Mee
author_facet Hwang, Sang Mee
author_sort Hwang, Sang Mee
collection PubMed
description The World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues was revised in 2017 on the basis of recent high-throughput sequencing and gene expression data on hematologic malignancies. This review explores the current WHO classification of acute myeloid leukemia (AML) and related precursor neoplasms, highlighting the changes made in the current edition and focusing on the diagnosis of AML.
format Online
Article
Text
id pubmed-7386892
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-73868922020-07-30 Classification of acute myeloid leukemia Hwang, Sang Mee Blood Res Review Article The World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues was revised in 2017 on the basis of recent high-throughput sequencing and gene expression data on hematologic malignancies. This review explores the current WHO classification of acute myeloid leukemia (AML) and related precursor neoplasms, highlighting the changes made in the current edition and focusing on the diagnosis of AML. Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2020-07-30 2019-07-30 /pmc/articles/PMC7386892/ /pubmed/32719169 http://dx.doi.org/10.5045/br.2020.S001 Text en © 2020 Korean Society of Hematology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Hwang, Sang Mee
Classification of acute myeloid leukemia
title Classification of acute myeloid leukemia
title_full Classification of acute myeloid leukemia
title_fullStr Classification of acute myeloid leukemia
title_full_unstemmed Classification of acute myeloid leukemia
title_short Classification of acute myeloid leukemia
title_sort classification of acute myeloid leukemia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386892/
https://www.ncbi.nlm.nih.gov/pubmed/32719169
http://dx.doi.org/10.5045/br.2020.S001
work_keys_str_mv AT hwangsangmee classificationofacutemyeloidleukemia

Ejemplares similares